EUDA — EUDA Health Holdings Ltd
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1847846 ·
Singapore
Last close
$16.20
Market Cap
$48.51M
52W High
$86.00
52W Low
$5.26
ADV30
23,283
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 1,716,562 | 345,145 | 5,984,084 |
| Dec 2024 | — | — | — | — | 1,697,810 | 237,605 | 4,269,878 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-52,873,188
Inventory
$2,844
Receivables
$334,202
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,820,264
EBITDA
$-2,236,242
Free Cash Flow
$-953,881
Enterprise Value
$27,469,192
Total Cash
$345,145
Total Debt
$2,401,371
Shares Out
2,994,325
Trailing EPS
$-1.48
Book Value
$-2.25
ROE
—
ROA
-89.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,820,264 | -2,440,512 | -2,772,762 | 1,716,562 | 5,984,084 | -4,254,945 | -2,426,535 |
| Dec 2024 | 4,011,005 | -2,579,571 | -15,357,156 | 1,697,810 | 4,269,878 | -2,553,059 | -2,034,727 |
| Dec 2023 | 3,706,458 | -3,961,054 | -10,039,481 | 1,310,508 | 8,792,444 | -7,498,551 | -2,917,895 |
| Dec 2022 | 3,764,295 | -5,880,612 | -24,884,122 | 25,629,040 | 29,136,071 | -3,520,509 | -1,526,828 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.60
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RNLXY | Renalytix plc | $48.31M | $4.00 | — |
| MDXH | MDxHealth SA | $52.29M | $0.55 | — |
| RENXF | Renalytix plc | $39.85M | $0.07 | — |
| DCGO | DocGo Inc. | $36.11M | $0.37 | — |
| ALPS | Alps Group Inc | $66.56M | $0.40 | — |
News headlines (Yahoo Finance, 1h cache)
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
2026-06-01 10:05 · Yahoo
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
2026-06-01 10:00 · Yahoo
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
2026-04-28 10:00 · Yahoo
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
2026-04-27 10:00 · Yahoo
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore
2026-08-26 10:00 · Yahoo
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products
2026-07-30 10:00 · Yahoo
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies
2026-07-28 10:00 · Yahoo
EUDA Health price target lowered to $2.75 from $6 at Greenridge
2026-03-10 14:00 · Yahoo
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital
2025-12-30 12:00 · Yahoo
Top Midday Gainers
2025-12-23 18:44 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.